Predictors of cognitive decline in older individuals with diabetes

Diabetes Care

Volumn 31, Issue 11, 2008, Pages 2103-2107

  Bruce, David G ^a   Davis, Wendy A ^a   Casey, Genevieve P ^a   Starkstein, Sergio E ^b   Clarnette, Roger M ^c   Almeida, Osvaldo P ^b   Davis, Timothy M E ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c FREMANTLE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INSULIN;

AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT; COGNITION; COGNITIVE DEFECT; CREATININE BLOOD LEVEL; DEMENTIA; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTOR VARIABLE; RISK FACTOR; DIABETES MELLITUS; DISEASE COURSE; LONGITUDINAL STUDY; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; STATISTICAL MODEL;

AGED; AGED, 80 AND OVER; COGNITION DISORDERS; DIABETES COMPLICATIONS; DIABETES MELLITUS; DISEASE PROGRESSION; FEMALE; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; NEUROPSYCHOLOGICAL TESTS; RISK FACTORS;

EID: 54549121996     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-0562     Document Type: Article

References (27)

1. Cukierman T, Gerstein HC, Williamson JD: Cognitive decline and dementia in diabetes-systematic overview of prospective studies. Diabetologia 48:2460-2469, 2005
2. Allen KV, Frier BM, Strachan MW: The relationship between type 2 diabetes and cognitive dysfunction: longitudinal studies. Eur J Pharmacol 490:169-175, 2004
3. Yaffe K, Blackwell T, Kanaya AM, David- owitz N, Barrett-Connor E, Krueger K: Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology 63:658-663, 2004
4. Luchsinger JA, Reitz C, Patel B, Tang M, Manly JJ, Mayeux R: Relation of diabetes to mild cognitive impairment. Arch Neurol 64:570-575, 2007
5. Peila R, Rodriguez BL, Launer LJ: Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study Diabetes 51: 1256 -1262, 2002
6. Xu WL, Qiu CX, Wahlin A, Winblad B, Fratiglioni L: Diabetes mellitus and the risk of dementia in the Kungsholmen project. Neurology 63:1181-1186, 2004
7. Cole AR, Astell A, Green C, Sutherland C: Molecular connections between dementia and diabetes. Neurosci Biobehav Rev 31:1046 -1063, 2007
8. Ott A, Stolk RP, van Harskamp F, Pols HAP, Hoffman A, Breteler M: Diabetes mellitus and the risk of dementia: The Rotterdam Study. Neurology 53:19371942, 1999
9. Gregg EW, Yaffe K, Cauley JA, Rolka DB, Blackwell TL, Narayan V, Cummings SR: Is diabetes associated with cognitive impairment and cognitive decline among older women? Arch Intern Med 160:174-180, 2000
10. Bruce DG, Davis WA, Casey G, Starkstein SE, Clarnette RC, Foster JK, FJ, Almeida OP, Davis TME: Predictors of cognitive impairment and dementia in older people with diabetes. Diabetologia 51:241-248, 2008
11. De Luis D, Fernandez N, Arranz M, Aller R, Izaola O: Total homocysteine and cognitive decline in people with type 2 diabetes. Diabetes Res Clin Pract 55:185-190, 2002
12. Kuo HK, Lin LY, Yu YH: Microalbuminuria is a negative correlate for cognitive function in older adults with peripheral arterial disease: results from the US National Health and Nutrition Examination Survey 1999-2002. J Intern Med 262: 562-570, 2007
13. Davis TM, Zimmet P, Davis WA, Bruce DG, Fida S, Mackay IR: Autoantibodies to glutamic acid decarboxylase in diabetic patients from a multi-ethnic Australian community: the Fremantle Diabetes Study. Diabet Med 17:667-674, 2000
14. Davis TME, Davis W, Mulder JW, Fortune P, Bruce DG: Silent myocardial infarction and its prognosis in a community-based cohort of diabetic patients: The Fremantle Diabetes Study. Diabetologia 47:395-399, 2004
15. Norman PE, Davis WA, Bruce DG, Davis TM: Peripheral arterial disease and risk of cardiac death in type 2 diabetes. Diabetes Care 29:575-580, 2006
16. Allen N, Ames D, Ashby D, Bennetts K, Tuckwell V, West C: A brief sensitive screening instrument for depression in late life. Age Ageing 23:213-218, 1994
17. Jorm AF: A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation. Psychol Med 24:145-153, 1994
18. Morris JC: The clinical dementia rating (CDR): current version and scoring rules. Neurology 43:2412-2414, 1993
19. Schmieder RE, Schrader J, Zidek W, Tebbe U, Paar WD, Bramlage P, Pittrow D, Bohm M: Low-grade albuminuria and cardiovascular risk. Clin Res Cardiol 96: 247-257, 2007
20. Kanaya AM, Barrett-Connor E, Gilden- gorin G, Yaffe K: Change in cognitive function by glucose tolerance status in older adults. Arch Intern Med 164:1327-1333, 2004
21. Wada M, Nagasawa H, Kurita K, Koyama S, Arawaka S, Kawanami T, Tajima K, Daimon M, Kato T: Microalbuminuria is a risk factor for cerebral small vessel disease in community-based elderly subjects. J Neurol Sci 255:27-34, 2007
22. Stehouwer C, Gall M, Twisk J, Knudsen E, Emeis JJ, Parving H: Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated and associated with death. Diabetes 51:1157-1165, 2002
23. Persson F, Rossing P, Hovind P, Stehouwer CDA, Schalwijk C, Tarnow L, Parving HH: Irbesartan treatment reduces biomarkers of inflammatory activity in patients with type 2 diabetes and microalbuminuria. Diabetes 55:3550-3555, 2006
24. Kehoe PG, Wilcock GK: Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease? Lancet Neurol 6:373-378, 2007
25. Rozzini L, Chilovi BV, Bertoletti E, Conti M, Del Rio I, Trabucchi M, Padovani A: Angiotensin converting enzyme (ACE) inhibitors modulate the rate of progression of amnestic mild cognitive impairment. Int J Geriatr Psychiatry 21:550-555, 2006
26. Khachaturian AS, Zandi PP, Lyketsos CG, Hayden KM, Skoog I, Norton MC, Tschanz JT, Mayer LS, Welsh-Bohmer KA, Breitner JC: Antihypertensive medication use and incident Alzheimer disease: the Cache County Study. Arch Neurol 63:686 -692, 2006
27. Panza F, D'Introno A, Colacicco AM, Capurso C, Del Parigi A, Caselli RJ, Pilotto A, Argentieri G, Scapicchio PL, Scafoto E, Capurso A, Solfrizzi V: Current epidemiology of mild cognitive impairment and other predementia syndromes. Am J Geriatr Psychiatry 13:633-644, 2005